Ken Griffin’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Ken Griffin's SMMT Position: Q3 2026 in Review
Ken Griffin increased its Summit Therapeutics (SMMT) stake by 119% in Q3 2026, buying an estimated $30.8M and bringing the position to 3,783,589 shares worth $64M. The position accounts for 0.01% of the portfolio, ranked #1333.
Ken Griffin first reported a position in SMMT in Q4 2018 and has held it in 19 quarters since. 298 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Ken Griffin held 3,783,589 shares of Summit Therapeutics worth $64M as of Q3 2026.
- Ken Griffin bought 2,057,873 Summit Therapeutics shares in Q3 2026, an estimated $30.8M.
- Summit Therapeutics made up 0.01% of Ken Griffin's portfolio in Q3 2026, its #1333 holding.
- Ken Griffin first reported a position in Summit Therapeutics in Q4 2018 and has held it in 19 quarters since.
- 298 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.